Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 6;6(6):CD002034.
doi: 10.1002/14651858.CD002034.pub2.

Biopsy versus resection for high-grade glioma

Michael G Hart  1 , Gareth Rl Grant, Emma F Solyom, Robin Grant
Affiliations

Biopsy versus resection for high-grade glioma

Michael G Hart et al. Cochrane Database Syst Rev. .

Abstract

Background: This is an update of the original review published in the Cochrane Database of Systematic Reviews Issue 1, 2000 and updated in 2003, 2007 and 2010.People with a presumed high-grade glioma (HGG) identified by clinical evaluation and radiological investigation have two initial surgical options: biopsy or resection. In certain situations, such as severe raised intracranial pressure, surgical resection is clinically indicated. Where surgical resection is not feasible, biopsy is the only reasonable option. Most people fall somewhere between these extremes, and in such circumstances it is uncertain which procedure is the best surgical option for the patient. Opinion is divided regarding the relative risks and benefits of each procedure.

Objectives: To estimate the clinical effectiveness of surgical resection compared to biopsy in people with a new presumptive diagnosis of HGG.

Search methods: We updated our searches of the following databases to 12 September 2018: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase. We also handsearched the Journal of Neuro-Oncology and Neuro-Oncology from 2010 to 2018 (including all conference abstracts).

Selection criteria: We included randomised controlled trials (RCTs) involving people of all ages with a presumed diagnosis of HGG based upon clinical and radiological investigation. Interventions included any form of biopsy or resection. Surgery was at the time of initial presentation and not for recurrence.

Data collection and analysis: Two reviews authors independently assessed the search results for relevance and undertook critical appraisal according to prespecified guidelines. Outcome measures included survival, time to progression/progression-free survival, quality of life, symptom control, adverse events, and mortality.

Main results: We identified a single RCT of biopsy versus resection in presumed HGG. No other articles met the inclusion criteria. Personal communication revealed that an RCT of biopsy versus resection in elderly people with HGG is underway. Further communication as part of this 2018 update revealed that the results of this study are due to be published in 2019.

Authors' conclusions: There is no high-quality evidence on biopsy versus resection for HGG that can be used to guide management. The single included RCT was of inadequate methodology to reach reliable conclusions. Further large, multicentred RCTs are required to conclusively answer the question of whether biopsy or resection is the best initial surgical management for HGG.

PubMed Disclaimer

Conflict of interest statement

Michael G Hart: None known Robin Grant: None known Gareth RL Grant: None known Emma F Solyom: None known

Update of

References

References to studies included in this review

Vuorinen 2003 {published data only}
    1. Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people ‐ a randomised study. Acta Neurochirurgica 2003;145:5‐10. - PubMed

References to studies excluded from this review

Brem 1995 {published data only}
    1. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo controlled trial of safety and efficacy of intra‐operative controlled delivery by biodegradable polymers of chemotherapy for recurrent glioma. Lancet 1995;345:1008‐12. - PubMed
Eljamel 2008 {published data only}
    1. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin(®) fluorescence‐guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers in Medical Science 2008;23:361‐7. - PubMed
Fadul 1988 {published data only}
    1. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH Jr, Posner JB. Morbidity and mortality of craniotomy for excision of supra‐tentorial gliomas. Neurology 1988;38(9):1374‐9. - PubMed
Gupta 2007 {published data only}
    1. Gupta DK, Chandra PS, Ojha BK, Sharma BS, Mahapatra AK, Mehta VS. Awake craniotomy versus surgery under general anaesthesia for resection of intrinsic lesions in eloquent cortex ‐ a prospective randomised study. Clinical Neurology and Neurosurgery 2007;109:335‐43. - PubMed
Proescholdt 2005 {published data only}
    1. Proescholdt MA, Macher C, Woertgen C, Brawanski A. Level of evidence in the literature concerning brain tumour resection. Clinical Neurology and Neurosurgery 2005;107:95‐8. - PubMed
Quigley 1991 {published data only}
    1. Quigley M, Maroon J. The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. Neurosurgery 1991;29(3):385‐9. - PubMed
Sawaya 1998 {published data only}
    1. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi W‐M, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumours. Neurosurgery 1998;42(5):1044‐55. - PubMed
Simpson 1993 {published data only}
    1. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of 3 consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. International Journal of Radiation Oncology 1993;26(2):239‐44. - PubMed
Stummer 2006 {published data only}
    1. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Roulen HJ, ALA Glioma Study Group. Fluorescence‐guided surgery with 5‐aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncology 2006;7:392‐401. - PubMed
Stummer 2008 {published data only}
    1. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62:564‐76. - PubMed
Taylor 2004 {published data only}
    1. Taylor M, Chambers A, Perry J, Bernstein M, the Neuro‐oncology Disease Site Group. Evidence‐based review of the role of surgery for malignant glioma. Current Oncology 2004;11(2):53‐62.
Tsitladikis 2010 {published data only}
    1. Tsitladikis A, Foroglou N, Venetis CA, Patsalas I, Hatzisotiriou A, Selviaridis P. Biopsy versus resection in the management of malignant gliomas: a systematic review and meta‐analysis. Journal of Neurosurgery 2010;112(5):1020‐32. - PubMed
Valtonen 1997 {published data only}
    1. Valtonen S, Timonen U, Toivanen P, Kalime H, Kivipelto L, Heiskanen O. Interstitial chemotherapy with carmustine‐loaded polymers for high grade gliomas: a randomized double‐blind study. Neurosurgery 1997;41:44‐8. - PubMed
Westphal 2003 {published data only}
    1. Westphal M, Hilt DC, Bortey E, Delavault R, Olivares R, Warnke PC, et al. A phase 3 trial of local chemotherapy with biodegradeable carmustine (BCNU) wafers (Gliadel® wafers) in patients with primary malignant glioma. Neuro‐Oncology 2003;5:79‐88. - PMC - PubMed
Westphal 2006 {published data only}
    1. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E, Executive Committee of the Gliadel Study Group. Gliadel® wafer in initial surgery for malignant glioma: long‐term follow‐up of a multicenter controlled trial. Acta Neurochir (Wien) 2006;148(3):269‐75. - PubMed
Whittle 1998 {published data only}
    1. Whittle IR, Pringle A‐M, Taylor R. Effects of resective surgery for left‐sided intracranial tumours on language function: a prospective study. Lancet 1998;351:1014‐6. - PubMed
Willems 2006 {published data only}
    1. Willems PW, Taphoorn MJ, Burger H, Berkelbach van der Sprenkel JW, Tulleken CAF. Effectiveness of neuronavigation in resecting solitary intracerebral contrast‐enhancing tumors: a randomized controlled trial. Journal of Neurosurgery 2006;104(3):360‐8. - PubMed
Wu 2007 {published data only}
    1. Wu JS, Zhou LF, Tang WJ, Mao Y, Hu J, Song YY, et al. Clinical evaluation and follow‐up outcome of diffusion tensor image‐based functional neuronavigation: a prospective, controlled study in patients with gliomas involving the pyramidal tracts. Neurosurgery 2007;61:935‐9. - PubMed

Additional references

Counsell 1998
    1. Counsell CE, Grant R. Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results. Journal of Neuro‐Oncology 1998;37(3):241‐50. - PubMed
CRD 2009
    1. Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: York Publishing Services Limited, 2009.
Curran 1993
    1. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group Malignant Glioma Trials. Journal of the National Cancer Institute 1993;85:704‐10. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
Devaux 1993
    1. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy and survival in malignant glial neoplasms. Journal of Neurosurgery 1993;78:767‐75. - PubMed
Fowkes 1991
    1. Fowkes FGR, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ 1991;302:1136‐40. - PMC - PubMed
Grant 2004
    1. Grant R. Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines. Journal of Neurology, Neurosurgery and Psychiatry 2004;75(Suppl II):i18‐23. - PMC - PubMed
Hall 1998
    1. Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82(9):1749‐55. - PubMed
Hart 2007
    1. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K. Chemotherapy wafers for high grade glioma. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD007294] - DOI - PubMed
Hensen 2008
    1. Hensen JW, Ulmer S, Harris GJ. Brain tumour imaging in clinical trials. American Journal of Neuroradiology 2008;29:419‐24. - PMC - PubMed
Higgins 2009
    1. Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Juni 2001
    1. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42‐6. - PMC - PubMed
Karnofsky 1948
    1. Karnofksy DA. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634‐56.
Kleihues 1993
    1. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathology 1993;3(3):255‐68. - PubMed
Kondziolka 1993
    1. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low‐grade) astrocytoma. Journal of Neurosurgery 1993;79(4):533‐6. - PubMed
Kreth 1993
    1. Kreth FW, Warnke PC, Scheremet R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. Journal of Neurosurgery 1993;78:762‐6. - PubMed
Lamborn 2004
    1. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro‐Oncology 2004;6:227‐35. - PMC - PubMed
Mauer 2008
    1. Mauer ME, Bottomley A, Taphoorn MB. Evaluating health‐related quality of life and symptom burden in brain tumour patients: instruments for use in clinical trials and clinical practice. Current Opinion in Neurology 2008;21:741‐53. - PubMed
MedRa 2008 [Computer program]
    1. www.meddramsso.com/MSSOWeb/index.htm. Medical Dictionary for Regulatory Authorities. www.meddramsso.com/MSSOWeb/index.htm, 2008.
Murphy 2002
    1. Murphy M, Loosemore A, Clifton AG, Howe FA, Tate AR, Cudlip SA, et al. The contribution of proton magnetic resonance spectroscopy (1H MRS) to clinical brain tumour diagnosis. British Journal of Neurosurgery 2002;16(4):329‐34. - PubMed
Nazzaro 1990
    1. Nazzaro J, Neuwelt E. The role of surgery in the management of supratentorial intermediate and high‐grade astrocytomas in adults. Journal of Neurosurgery 1990;73:331‐4. - PubMed
NICE 2007
    1. National Institute for Health and Clinical Excellence. Improving outcomes for people with brain and other CNS tumours ‐ the manual. https://www.nice.org.uk. [https://www.nice.org.uk/guidance/csg10/resources/improving‐outcomes‐for‐...
Parmar 1998
    1. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature of endpoints. Statistics in Medicine 1998;17:2815‐34. - PubMed
Rampling 2005
    1. Rampling R, James A, Papanastassiou V. The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy. Journal of Neurology, Neurosurgery and Psychiatry 2005;75(Suppl II):ii24‐30. - PMC - PubMed
Review Manager 5 [Computer program]
    1. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen. Version 5.3. Copenhagen. The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schiff 2003
    1. Schiff D, Shaffrey ME. Role of resection for newly diagnosed malignant gliomas. Expert Review of Anticancer Therapy 2003;3(5):621‐30. - PubMed
Wen 2010
    1. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria in high grade gliomas: response assessment in Neuro‐oncology working group. Journal of Clinical Oncology 2010;28(11):1963‐72. - PubMed
WHO 1982
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982;5:649‐55. - PubMed
Woodworth 2005
    1. Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Accuracy of frameless and frame‐based image‐guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open specimen. Neurological Research 2005;27:358‐62. - PubMed

Publication types